Clinicians at NHS Greater Glasgow and Clyde are now using a head CT AI solution from Qure.ai to support faster decision-making about the care, management and discharge of patients with head injuries. Healthcare clinicians…
Continue Reading
deepc GmbH has acquired medical imaging software solution Osimis Platform, strengthening its AI infrastructure for radiology at scale, and enhancing its capabilities and product offering.The strategic acquisition by deepc, an AI operating system for…
Continue Reading
University Hospitals of Leicester NHS Trust has gone live with an AI-powered chest x-ray solution, as part of the multi-NHS site LungIMPACT research study.The trust is using Qure.ai’s qXR AI which is integrated into…
Continue Reading
Qure.ai, a leader in medical imaging AI, achieves FDA breakthrough device status for its qSpot-TB solution, enhancing its regulatory standing alongside four FDA clearances and 61 EU MDR CE marks within 18 months. qSpot-TB,…
Continue Reading
The collaborative LungIMPACT study which is gathering real-world evidence of AI-assisted diagnosis of lung cancer, is welcoming East Suffolk and North Essex NHS Foundation Trust.The study brings together UK academia and NHS trusts and…
Continue Reading
Qure.ai, a trailblazer in medical imaging solutions, celebrates its 13th FDA clearance with qXR-LN, an AI-powered tool for lung nodule detection. This pioneering technology signifies Qure.ai’s supremacy in AI-driven advancements for plain film radiography…
Continue Reading
A digital health collaboration is to evaluate the use of AI in chest x-rays in Glasgow, with the Scottish government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde jointly working to assess…
Continue Reading
Qure.ai has announced its integration into deepc’s AI platform, deepcOS, in a strategic move that will help enhance patient care workflows and address the escalating demands on radiologists.The new partnership will see Qure.ai’s CE…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
Qure.ai, a prominent medical AI firm, has received FDA clearance for its qXR chest X-ray solution, enabling the triage of pneumothorax and pleural effusion. Qure.ai’s qXR algorithm demonstrated exceptional accuracy and rapid notification capabilities….
Continue Reading
